However, its essential to rule out more concerning causes like gastrointestinal bleeding
Thus, patients taking the agents associated with the greatest weight loss, tirzepatide and semaglutide, have the highest incidence of developing both hypocalcemia and hypercalcemia
To be eligible, patients must: Be 18 years or older and not pregnant Have a Body Mass Index (BMI) of 30 kg/m to qualify for any of the medications, or Have a BMI of 27 kg/m with at least one weight-related risk factor (e.g., high blood pressure, type 2 diabetes, high cholesterol) to start Phentermine, Phentermine +Topiramate, Metformin, or compounded Tirzepatide, or Have a BMI of 25 kg/m with at least one weight-related risk factor (e.g
GHRP-2 (Growth Hormone Releasing Peptide) is a 2nd-generation Growth Hormone Secretagogue (GSH)
It may be injected superficially (mesotherapeutic technique) in areas with wrinkles or lax skin to boost collagen